首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure
【2h】

Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure

机译:关于α1甘氨酸受体跨膜结构的变构和高位突变突变型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The glycine receptor (GlyR) is a pentameric ligand-gated ion channel (pLGIC) mediating inhibitory transmission in the nervous system. Its transmembrane domain (TMD) is the target of allosteric modulators such as general anesthetics and ethanol and is a major locus for hyperekplexic congenital mutations altering the allosteric transitions of activation or desensitization. We previously showed that the TMD of the human α1GlyR could be fused to the extracellular domain of GLIC, a bacterial pLGIC, to form a functional chimera called Lily. Here, we overexpress Lily in Schneider 2 insect cells and solve its structure by X-ray crystallography at 3.5 Å resolution. The TMD of the α1GlyR adopts a closed-channel conformation involving a single ring of hydrophobic residues at the center of the pore. Electrophysiological recordings show that the phenotypes of key allosteric mutations of the α1GlyR, scattered all along the pore, are qualitatively preserved in this chimera, including those that confer decreased sensitivity to agonists, constitutive activity, decreased activation kinetics, or increased desensitization kinetics. Combined structural and functional data indicate a pore-opening mechanism for the α1GlyR, suggesting a structural explanation for the effect of some key hyperekplexic allosteric mutations. The first X-ray structure of the TMD of the α1GlyR solved here using GLIC as a scaffold paves the way for mechanistic investigation and design of allosteric modulators of a human receptor.
机译:甘氨酸受体(GlyR)是五聚体配体门控离子通道(pLGIC),可在神经系统中介导抑制性传递。它的跨膜结构域(TMD)是变构调节剂(例如全身麻醉剂和乙醇)的靶标,并且是高脚先天性突变(激活或脱敏的变构转变)改变的主要场所。我们之前曾证明,人α1GlyR的TMD可以与细菌pLGIC GLIC的胞外域融合,形成称为Lily的功能性嵌合体。在这里,我们在Schneider 2昆虫细胞中过量表达了Lily,并通过X射线晶体学以3.5Å的分辨率解析了其结构。 α1GlyR的TMD采用闭孔构象,在孔的中心包括疏水残基的单环。电生理学记录表明,在整个嵌合体中定性地保留了沿孔散布的α1GlyR关键变构突变的表型,包括那些对激动剂的敏感性降低,组成活性,激活动力学降低或脱敏动力学增强的嵌合体。结合的结构和功能数据表明了α1GlyR的开孔机制,这为某些关键的高位变构变构效应的结构解释提供了解释。使用GLIC作为支架解决的α1GlyRTMD的第一个X射线结构为人类受体的变构调节剂的机械研究和设计铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号